All news

Cigna (CI) Stock May Still Be A Bargain After Lead To One Vision

Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash

Cigna Group's stock has seen a 48.5% gain over the past five years, prompting a review of whether its current price is justified by its earnings. Trading at a P/E ratio of 12.2x, Cigna is discounted compared to the broader healthcare sector and its peers, suggesting it may be undervalued based on earnings.

Read original source

CI company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.